MedPath

Comparison of efficacy and complications of Nasal intermittent positive pressure ventilation (NIPPV) and nasal continuous positive airway pressure (NCPAP) in preterm infants

Not Applicable
Conditions
respiratory distress in neonates.
Respiratory distress syndrome of newborns
p22,p22.0,
Registration Number
IRCT201202273250N6
Lead Sponsor
Kerman university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
120
Inclusion Criteria

All consecutively born preterm infants with gestational age 28 to 36 weeks, admitted to Afzalipour neonatal intensive care unit with respiratory distress and silverman- Anderson retraction score of 6 and 7. Exclusion criteria: Babies were excluded if there was signiicant morbidity apart from RDS including cardiac disease, congenital malformation including congenital diapheragmatic hernia, tracheoeso phageal fistula and cleft lip/palate, babies with respiratory distress secondary to severe asphyxia (Apgar score <3 at 1 and 5 minute or PH<7/12 or if they had cardiovascular or respiratory instability because of sepsis, anemia or severe intraventriculare hemorrhage (IVH) on admission.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response to treatment. Timepoint: During hospitalization and using NCPAPand NIPPV. Method of measurement: comparing survival rates.
Secondary Outcome Measures
NameTimeMethod
Incidence of pneumothorax. Timepoint: During hospitalization and using NCPAPand NIPPV. Method of measurement: Taking chest x rays on admission and deterioration of clinical status.;Incidence of PDA. Timepoint: During hospitalization and using NCPAPand NIPPV. Method of measurement: Echo cardiography on admission and deterioration of clinical status.;Incidence of IVH. Timepoint: During hospitalization and using NCPAPand NIPPV. Method of measurement: Cranial ultra sonography on admission and deterioration of clinical status.
© Copyright 2025. All Rights Reserved by MedPath